Factors Associated With Prolonged Viral RNA Shedding in Patients with Coronavirus Disease 2019 (COVID-19)
- PMID: 32271376
- PMCID: PMC7184421
- DOI: 10.1093/cid/ciaa351
Factors Associated With Prolonged Viral RNA Shedding in Patients with Coronavirus Disease 2019 (COVID-19)
Abstract
Background: An outbreak of coronavirus disease 2019 (COVID-19) is becoming a public health emergency. Data are limited on the duration and host factors related to viral shedding.
Methods: In this retrospective study, risk factors associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA shedding were evaluated in a cohort of 113 symptomatic patients from 2 hospitals outside Wuhan.
Results: The median (interquartile range) duration of SARS-CoV-2 RNA detection was 17 (13-22) days as measured from illness onset. When comparing patients with early (<15 days) and late (≥15 days after illness onset) viral RNA clearance, prolonged SARS-CoV-2 RNA shedding was associated with male sex (P = .009), old age (P = .033), concomitant hypertension (P = .009), delayed admission to hospital after illness onset (P = .001), severe illness at admission (P = .049), invasive mechanical ventilation (P = .006), and corticosteroid treatment (P = .025). Patients with longer SARS-CoV-2 RNA shedding duration had slower recovery of body temperature (P < .001) and focal absorption on radiograph images (P < .001) than patients with early SARS-CoV-2 RNA clearance. Male sex (OR, 3.24; 95% CI, 1.31-8.02), delayed hospital admission (OR, 1.30; 95% CI, 1.10-1.54), and invasive mechanical ventilation (OR, 9.88; 95% CI, 1.11-88.02) were independent risk factors for prolonged SARS-CoV-2 RNA shedding.
Conclusions: Male sex, delayed admission to hospital after illness onset, and invasive mechanical ventilation were associated with prolonged SARS-CoV-2 RNA shedding. Hospital admission and general treatments should be started as soon as possible in symptomatic COVID-19 patients, especially male patients.
Keywords: COVID-19; SARS-COV-2; coronavirus; risk factors; viral shedding.
© The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.
Similar articles
-
Clinical Characteristics and Factors Associated With Long-Term Viral Excretion in Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection: a Single-Center 28-Day Study.J Infect Dis. 2020 Aug 17;222(6):910-918. doi: 10.1093/infdis/jiaa388. J Infect Dis. 2020. PMID: 32614392 Free PMC article.
-
Prolonged shedding of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) RNA among patients with coronavirus disease 2019 (COVID-19).Infect Control Hosp Epidemiol. 2020 Oct;41(10):1235-1236. doi: 10.1017/ice.2020.307. Epub 2020 Jun 24. Infect Control Hosp Epidemiol. 2020. PMID: 32578527 Free PMC article. No abstract available.
-
The presence of SARS-CoV-2 RNA in the feces of COVID-19 patients.J Med Virol. 2020 Jul;92(7):833-840. doi: 10.1002/jmv.25825. Epub 2020 Apr 25. J Med Virol. 2020. PMID: 32243607
-
Ocular Symptoms of SARS-CoV-2: Indication of Possible Ocular Transmission or Viral Shedding.Ocul Immunol Inflamm. 2020 Nov 16;28(8):1269-1279. doi: 10.1080/09273948.2020.1799035. Epub 2020 Sep 1. Ocul Immunol Inflamm. 2020. PMID: 32870054 Review.
-
Role of SARS-CoV-2 neurotropism and neuroinvasion in COVID-19 patients disease severity.Gac Med Mex. 2020;156(4):339-343. doi: 10.24875/GMM.20000307. Gac Med Mex. 2020. PMID: 32831327 Review. English.
Cited by
-
Antiviral anticoagulation.Res Pract Thromb Haemost. 2020 Jul 6;4(5):774-788. doi: 10.1002/rth2.12406. eCollection 2020 Jul. Res Pract Thromb Haemost. 2020. PMID: 32685886 Free PMC article. Review.
-
COVID-19 in people living with HIV: Clinical implications of dynamics of the immune response to SARS-CoV-2.J Med Virol. 2021 Mar;93(3):1796-1804. doi: 10.1002/jmv.26556. Epub 2020 Oct 8. J Med Virol. 2021. PMID: 32975842 Free PMC article.
-
Tools and Techniques for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)/COVID-19 Detection.Clin Microbiol Rev. 2021 May 12;34(3):e00228-20. doi: 10.1128/CMR.00228-20. Print 2021 Jun 16. Clin Microbiol Rev. 2021. PMID: 33980687 Free PMC article. Review.
-
Perspectives on glucocorticoid treatment for COVID-19: a systematic review.Pharmacol Rep. 2021 Jun;73(3):728-735. doi: 10.1007/s43440-021-00225-3. Epub 2021 Mar 5. Pharmacol Rep. 2021. PMID: 33666864 Free PMC article.
-
Sex differences in SARS-CoV-2 infection rates and the potential link to prostate cancer.Commun Biol. 2020 Jul 8;3(1):374. doi: 10.1038/s42003-020-1088-9. Commun Biol. 2020. PMID: 32641750 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous